C8ORF33 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.83963955180388E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.530509218308E-14 |
Normal-vs-Stage2 |
2.808200E-01 |
Normal-vs-Stage3 |
5.12830000687359E-10 |
Normal-vs-Stage4 |
4.06529999663618E-08 |
Stage1-vs-Stage2 |
2.740400E-01 |
Stage1-vs-Stage3 |
9.767800E-01 |
Stage1-vs-Stage4 |
3.348400E-01 |
Stage2-vs-Stage3 |
2.889000E-01 |
Stage2-vs-Stage4 |
4.165000E-01 |
Stage3-vs-Stage4 |
4.770800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.76458888904108E-13 |
Normal-vs-AfricanAmerican |
7.21659999980417E-07 |
Normal-vs-Asian |
8.026400E-01 |
Caucasian-vs-AfricanAmerican |
3.269400E-01 |
Caucasian-vs-Asian |
1.397780E-01 |
AfricanAmerican-vs-Asian |
8.281600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.38659972392929E-10 |
Normal-vs-Female |
2.12909689878416E-11 |
Male-vs-Female |
8.991000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.351200E-01 |
Normal-vs-Age(41-60Yrs) |
1.84363635469253E-12 |
Normal-vs-Age(61-80Yrs) |
5.00399721659051E-12 |
Normal-vs-Age(81-100Yrs) |
4.94009999996159E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.297000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.577200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.194400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.456400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.817800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.459200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.379300E-03 |
Normal-vs-Grade 2 |
1.80244708047894E-12 |
Normal-vs-Grade 3 |
5.99520433297585E-15 |
Normal-vs-Grade 4 |
1.121560E-01 |
Grade 1-vs-Grade 2 |
4.274600E-01 |
Grade 1-vs-Grade 3 |
2.065000E-01 |
Grade 1-vs-Grade 4 |
7.874800E-01 |
Grade 2-vs-Grade 3 |
1.685830E-01 |
Grade 2-vs-Grade 4 |
3.397200E-01 |
Grade 3-vs-Grade 4 |
1.814640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62458935193399E-12 |
Normal-vs-ccB subtype |
4.246900E-04 |
ccA subtype-vs-ccB subtype |
7.833900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.50732767881345E-12 |
Normal-vs-N1 |
8.211900E-02 |
N0-vs-N1 |
8.346400E-02 |
|
|